Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Sebastian

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
NPJ Vaccines|March 3, 2021
ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challengeRobert J Fischer, Jyothi N Purushotham, Neeltje van Doremalen, et al.
Vaccines|June 27, 2024
Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBVCharlotte Davis, Dave Singh, Katie Anderson, et al.
Plos Pathogens|June 26, 2024
Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruseAmy Flaxman, Sarah Sebastian, Sofia Appelberg, et al.
NPJ Vaccines|June 26, 2024
Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccineCameron Bissett, Sandra Belij-Rammerstorfer, Marta Ulaszewska, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2025
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-Risk Human Papillomavirus Vaccine in Women with Low-grade Cervical LesionsKarin Hellner, Philippe Simon, Philippe De Sutter, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
NPJ Vaccines|March 3, 2021
ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challengeRobert J Fischer, Jyothi N Purushotham, Neeltje van Doremalen, et al.
Vaccines|June 27, 2024
Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBVCharlotte Davis, Dave Singh, Katie Anderson, et al.
Plos Pathogens|June 26, 2024
Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruseAmy Flaxman, Sarah Sebastian, Sofia Appelberg, et al.
NPJ Vaccines|June 26, 2024
Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccineCameron Bissett, Sandra Belij-Rammerstorfer, Marta Ulaszewska, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2025
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-Risk Human Papillomavirus Vaccine in Women with Low-grade Cervical LesionsKarin Hellner, Philippe Simon, Philippe De Sutter, et al.
Pageof 4